P3.12.46 Enhanced vs Standard Dermatologic Management With Amivantamab-Lazertinib in EGFRm Advanced NSCLC: The COCOON Global RCT
B.C. Cho(Yonsei University), Wei Li(Sichuan University), A.I. Spira(Virginia Cancer Specialists), Maxwell Sauder(Princess Margaret Cancer Centre), Jerome A. Feldman(Walgreens Boots Alliance (United States)), F. Bozorgmehr(Heidelberg University), Mei Ting Mak(Instituto do Câncer do Estado de São Paulo), J. E. Smith(University of California, Irvine), P.J. Voon(Sarawak General Hospital), Panwen Tian(Sichuan University), J-L. Tan(University of Malaya), Cheng‐Ta Yang(Linkou Chang Gung Memorial Hospital), J-Y. Shih(National Taiwan University Hospital), Nuri Karadurmuş(Gülhane Askerî Tıp Akademisi), J.E. Cundom(Instituto Argentino de Diagnóstico y Tratamiento), Glaucio Bertollo(Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória), I. Cicin(Istinye University), J. Nieva(USC Norris Comprehensive Cancer Center), Ana Laura Ortega Granados(Complejo Hospitalario de Jaén), P. Tomasini(Aix-Marseille Université), Danny Nguyen(City Of Hope National Medical Center), E. Felip(Hebron University), J. Schuchard(Johnson & Johnson (United States)), Shane Murphy(Johnson & Johnson (United States)), Bruce G. Anderson(Johnson & Johnson (United States)), T. Romero(Johnson & Johnson (United States)), Yu Xia(Johnson & Johnson (United States)), S. Sheng(Johnson & Johnson (United States)), J.M. Bauml(Johnson & Johnson (United States)), Parthiv J. Mahadevia(Johnson & Johnson (United States)), Juinn Huar Kam(Johnson & Johnson (United States)), Mehregan Nematian‐Samani(Johnson & Johnson (United States)), Jorge Simões(Johnson & Johnson (United States)), Mark Wildgust(Johnson & Johnson (United States)), N. Girard(Université de Versailles Saint-Quentin-en-Yvelines)
Cited by 1
Abstract
Related Papers
No related papers found
Powered by citation graph analysis